Position in NTRA
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$284,479
New position
Shares Held
1,048
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#616
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $12,975,489 across 11 Diagnostics & Research names. NTRA ranks #11 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,469 | $3,744,655 | |
| 2 | DHR |
Danaher Corp /De/
|
14,159 | $2,697,004 | |
| 3 | ILMN |
Illumina, Inc.
|
12,679 | $2,229,347 | |
| 4 | WAT |
Waters Corp /De/
|
2,310 | $866,340 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
1,362 | $717,010 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,058 | $648,142 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
495 | $632,365 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
2,177 | $420,639 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $284,479 | 1,048 | Shares | Other | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||